Achieve Life Sciences, Inc.
ACHV
$5.10
$0.255.16%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -12.63% | -37.21% | -58.90% | -83.07% | -68.98% |
| Total Depreciation and Amortization | -4.70% | -0.44% | 0.44% | 1.31% | 3.08% |
| Total Amortization of Deferred Charges | 35.14% | 126.09% | 511.11% | -- | -- |
| Total Other Non-Cash Items | -25.59% | 24.02% | 41.30% | 32.99% | 24.95% |
| Change in Net Operating Assets | -78.08% | -276.87% | 80.28% | 66.89% | 448.99% |
| Cash from Operations | -27.38% | -66.16% | -63.07% | -101.52% | -65.72% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 188.33% | 128.31% | 151.41% | 192.43% | -- |
| Cash from Investing | 188.33% | 128.32% | 151.40% | 192.39% | -48,600.00% |
| Total Debt Issued | -49.05% | -49.05% | -100.00% | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -- | -- |
| Issuance of Common Stock | 5,281.27% | -18.34% | -18.38% | -24.99% | -98.79% |
| Repurchase of Common Stock | -- | -- | 100.00% | 100.00% | 30.45% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 779.78% | 6.18% | -3.97% | -39.61% | -110.63% |
| Foreign Exchange rate Adjustments | 300.00% | -- | 0.00% | 100.00% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 128.62% | 389.62% | 315.15% | 458.80% | -207.08% |